The future of the pharmaceutical, biological and medical device industry
Lesley J Burgess, Marli TerblancheTREAD Research/Cardiology Unit, Department of Internal Medicine, Tygerberg Hospital and University of Stellenbosch, Parow, South AfricaAbstract: Numerous factors contribute to the declining pharmaceutical industry on the one hand and the rapidly growing generic indu...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-09-01
|
Series: | Open Access Journal of Clinical Trials |
Online Access: | http://www.dovepress.com/the-future-of-the-pharmaceutical-biological-and-medical-device-industr-a8231 |
id |
doaj-130cbe56125d4cd18a20dfe3b98a1550 |
---|---|
record_format |
Article |
spelling |
doaj-130cbe56125d4cd18a20dfe3b98a15502020-11-24T22:50:28ZengDove Medical PressOpen Access Journal of Clinical Trials1179-15192011-09-012011default4550The future of the pharmaceutical, biological and medical device industryBurgess LJTerblanche MLesley J Burgess, Marli TerblancheTREAD Research/Cardiology Unit, Department of Internal Medicine, Tygerberg Hospital and University of Stellenbosch, Parow, South AfricaAbstract: Numerous factors contribute to the declining pharmaceutical industry on the one hand and the rapidly growing generic industry together with the growing importance of medical devices and biologicals on the other. It is clear that the pharmaceutical industry is going to undergo a change in the next decade in order to meet the current challenges facing it and ultimately sustain its profitability and growth. This paper aims to identify a number of fairly obvious trends that are likely to have a significant impact on the product development pipeline in the next decade. It is more than clear that the current production pipeline for pharmaceutical, biotechnology and medical device industries is no longer sustainable and that urgent interventions are required in order to maintain its current level of profitability.Keywords: pharmaceutical industry, personalized medicine, trends, generics, biotechnologyhttp://www.dovepress.com/the-future-of-the-pharmaceutical-biological-and-medical-device-industr-a8231 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Burgess LJ Terblanche M |
spellingShingle |
Burgess LJ Terblanche M The future of the pharmaceutical, biological and medical device industry Open Access Journal of Clinical Trials |
author_facet |
Burgess LJ Terblanche M |
author_sort |
Burgess LJ |
title |
The future of the pharmaceutical, biological and medical device industry |
title_short |
The future of the pharmaceutical, biological and medical device industry |
title_full |
The future of the pharmaceutical, biological and medical device industry |
title_fullStr |
The future of the pharmaceutical, biological and medical device industry |
title_full_unstemmed |
The future of the pharmaceutical, biological and medical device industry |
title_sort |
future of the pharmaceutical, biological and medical device industry |
publisher |
Dove Medical Press |
series |
Open Access Journal of Clinical Trials |
issn |
1179-1519 |
publishDate |
2011-09-01 |
description |
Lesley J Burgess, Marli TerblancheTREAD Research/Cardiology Unit, Department of Internal Medicine, Tygerberg Hospital and University of Stellenbosch, Parow, South AfricaAbstract: Numerous factors contribute to the declining pharmaceutical industry on the one hand and the rapidly growing generic industry together with the growing importance of medical devices and biologicals on the other. It is clear that the pharmaceutical industry is going to undergo a change in the next decade in order to meet the current challenges facing it and ultimately sustain its profitability and growth. This paper aims to identify a number of fairly obvious trends that are likely to have a significant impact on the product development pipeline in the next decade. It is more than clear that the current production pipeline for pharmaceutical, biotechnology and medical device industries is no longer sustainable and that urgent interventions are required in order to maintain its current level of profitability.Keywords: pharmaceutical industry, personalized medicine, trends, generics, biotechnology |
url |
http://www.dovepress.com/the-future-of-the-pharmaceutical-biological-and-medical-device-industr-a8231 |
work_keys_str_mv |
AT burgesslj thefutureofthepharmaceuticalbiologicalandmedicaldeviceindustry AT terblanchem thefutureofthepharmaceuticalbiologicalandmedicaldeviceindustry AT burgesslj futureofthepharmaceuticalbiologicalandmedicaldeviceindustry AT terblanchem futureofthepharmaceuticalbiologicalandmedicaldeviceindustry |
_version_ |
1725672411648491520 |